Tabrecta

Tabrecta ATC Classification

capmatinib

Manufacturer:

Novartis

Distributor:

Zuellig

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Patient Counseling Information MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Full Prescribing Info

ATC Classification

L01EX17 - capmatinib ; Belongs to the class of other protein kinase inhibitors. Used in the treatment of cancer.

Sign up for Free to Continue Reading

Continue with Google

Sign up with email

Already a member? Sign in